Owlstone Medical Nets Millions in Investment Round
The funds will finance the commercial launch of breath biomarker research and development services and clinical trials in lung and colon cancer screening.
Read More
Search Results for: lung cancer
Campaign Highlights Comprehensive Genomic Testing to Advance Precision Medicine in Lung Cancer
The campaign is focused on empowering patients with lung cancer and their caregivers to initiate a dialogue with their physicians about comprehensive genomic testing and its potential to expand treatment options for the patient.
Read MoreStudy Identifies NSCLC Patients Who Are More Likely to Have Improved Progression-Free Survival on Third-Generation EGFR-TKI Therapy
The blood-based proteomic test helps identify non-small cell lung cancer patients for epidermal growth factor receptor tyrosine kinase inhibitor therapy.
Read MoreThermo Fisher Submits PMA for NGS-Based Universal Gene Panel
If approved, the panel could be the first of its kind in the United States, and would serve as a companion diagnostic utilized to select patients for specific non-small cell lung cancer therapies.
Read More
Independent Data Demonstrate Clinical Utility of NSCLC Tests
The blood-based tests offer results to ordering physicians within 72 hours.
Read More